However, it is technically challenging for us to investigate the stimulation of CD4+ and CD8+ T cells in vivo and its direct effect on tumor burden in Med23 knockout mice and the detailed mechanism needs to be further studied. The gene discussed is CD4; the disease is neoplasm.